192 related articles for article (PubMed ID: 16849499)
1. Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.
Bora NS; Kaliappan S; Jha P; Xu Q; Sohn JH; Dhaulakhandi DB; Kaplan HJ; Bora PS
J Immunol; 2006 Aug; 177(3):1872-8. PubMed ID: 16849499
[TBL] [Abstract][Full Text] [Related]
2. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization.
Bora PS; Sohn JH; Cruz JM; Jha P; Nishihori H; Wang Y; Kaliappan S; Kaplan HJ; Bora NS
J Immunol; 2005 Jan; 174(1):491-7. PubMed ID: 15611275
[TBL] [Abstract][Full Text] [Related]
3. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.
Schnabolk G; Coughlin B; Joseph K; Kunchithapautham K; Bandyopadhyay M; O'Quinn EC; Nowling T; Rohrer B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1850-63. PubMed ID: 25593023
[TBL] [Abstract][Full Text] [Related]
4. The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.
Rohrer B; Coughlin B; Kunchithapautham K; Long Q; Tomlinson S; Takahashi K; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):e1-8. PubMed ID: 21257205
[TBL] [Abstract][Full Text] [Related]
5. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
Rohrer B; Coughlin B; Bandyopadhyay M; Holers VM
J Ocul Pharmacol Ther; 2012 Aug; 28(4):402-9. PubMed ID: 22309197
[TBL] [Abstract][Full Text] [Related]
6. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
7. Role of ocular complement factor H in a murine model of choroidal neovascularization.
Lyzogubov VV; Tytarenko RG; Jha P; Liu J; Bora NS; Bora PS
Am J Pathol; 2010 Oct; 177(4):1870-80. PubMed ID: 20813971
[TBL] [Abstract][Full Text] [Related]
8. CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration.
Bora NS; Kaliappan S; Jha P; Xu Q; Sivasankar B; Harris CL; Morgan BP; Bora PS
J Immunol; 2007 Feb; 178(3):1783-90. PubMed ID: 17237428
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
Parsons N; Annamalai B; Obert E; Schnabolk G; Tomlinson S; Rohrer B
Mol Immunol; 2019 Apr; 108():8-12. PubMed ID: 30763805
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
11. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
Banda NK; Thurman JM; Kraus D; Wood A; Carroll MC; Arend WP; Holers VM
J Immunol; 2006 Aug; 177(3):1904-12. PubMed ID: 16849503
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
13. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.
Liu J; Jha P; Lyzogubov VV; Tytarenko RG; Bora NS; Bora PS
J Biol Chem; 2011 Jun; 286(23):20991-1001. PubMed ID: 21515678
[TBL] [Abstract][Full Text] [Related]
14. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
Elvington A; Atkinson C; Zhu H; Yu J; Takahashi K; Stahl GL; Kindy MS; Tomlinson S
J Immunol; 2012 Nov; 189(9):4640-7. PubMed ID: 23028050
[TBL] [Abstract][Full Text] [Related]
15. Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.
Poor SH; Qiu Y; Fassbender ES; Shen S; Woolfenden A; Delpero A; Kim Y; Buchanan N; Gebuhr TC; Hanks SM; Meredith EL; Jaffee BD; Dryja TP
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6525-34. PubMed ID: 25205860
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
Banda NK; Takahashi K; Wood AK; Holers VM; Arend WP
J Immunol; 2007 Sep; 179(6):4101-9. PubMed ID: 17785849
[TBL] [Abstract][Full Text] [Related]
17. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TRAF6 alleviates choroidal neovascularization in vivo.
Ding D; Zhu M; Liu X; Jiang L; Xu J; Chen L; Liang J; Li L; Zhou T; Wang Y; Shi H; Yuan Y; Song E
Biochem Biophys Res Commun; 2018 Sep; 503(4):2742-2748. PubMed ID: 30103950
[TBL] [Abstract][Full Text] [Related]
19. Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.
Banda NK; Levitt B; Wood AK; Takahashi K; Stahl GL; Holers VM; Arend WP
Clin Exp Immunol; 2010 Jan; 159(1):100-8. PubMed ID: 19843088
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA-ZBTB44 regulates the development of choroidal neovascularization.
Zhou RM; Shi LJ; Shan K; Sun YN; Wang SS; Zhang SJ; Li XM; Jiang Q; Yan B; Zhao C
Theranostics; 2020; 10(7):3293-3307. PubMed ID: 32194869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
